LRMR Price / Book | LARIMAR THERAPEUTICS, INC.

LARIMAR THERAPEUTICS, INC. (LRMR) Price / Book

2026-09-03: Price/Book Ratio 3.13.
2026-06-30: Price/Book Ratio 2.49.
2026-03-31: Price/Book Ratio 2.96.
2025-12-31: Price/Book Ratio 4.05.

Historical market capitalization divided by filed shareholder equity.

Available history: 2014-06-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	3.13
2026-06-30	2.49
2026-03-31	2.96
2025-12-31	4.05
2025-09-30	1.99
2025-06-30	1.54
2025-03-31	0.95
2024-12-31	1.44
2024-09-30	2.11
2024-06-30	2.19
2024-03-31	2.1
2023-12-31	2.44
2023-09-30	1.87
2023-06-30	1.36
2023-03-31	1.84
2022-12-31	1.61
2022-09-30	1.17
2022-06-30	0.69
2022-03-31	1.26
2021-12-31	2.97
2021-09-30	2.83
2021-06-30	2.23
2021-03-31	2.85
2020-12-31	3.67
2020-09-30	2.27
2020-06-30	1.75
2020-03-31	153.47
2019-09-30	174.7
2019-06-30	981.64
2019-03-31	1,002.6
2018-12-31	760.08
2018-09-30	49.76
2018-06-30	65.08
2018-03-31	37.91
2017-12-31	19.48
2017-09-30	13.01
2017-06-30	11.61
2017-03-31	13.81
2016-12-31	8.57
2016-09-30	8.34
2016-06-30	13.78
2016-03-31	14.15
2015-12-31	12.16
2015-09-30	55.04
2015-06-30	54.65
2015-03-31	57.59
2014-12-31	81.07
2014-09-30	48.15
2014-06-30	42.97

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Emergent BioSolutions Inc. (EBS)	United States	$0.347B	-2.43
ENANTA PHARMACEUTICALS INC (ENTA)	United States	$0.349B	-6.72
Benitec Biopharma Inc. (BNTC)	United States	$0.337B	-10.08
BioAge Labs, Inc. (BIOA)	United States	$0.333B	-11.88
Vogenx, Inc. (VOGX)	United States	$0.355B
BridgeBio Oncology Therapeutics, Inc. (BBOT)	United States	$0.320B	-3.35
Evommune, Inc. (EVMN)	United States	$0.320B	-5.10
Prelude Therapeutics Inc (PRLD)	United States	$0.318B	-7.01
ABEONA THERAPEUTICS INC. (ABEO)	United States	$0.312B	-5.63
GT Biopharma, Inc. (GTBP)	United States	$0.309B	-4.58